A Nodular Foreign Body Reaction in a Dialysis Patient Receiving Long-term Treatment with Lanthanum Carbonate

American Journal of Kidney Diseases

Volumn 67, Issue 1, 2016, Pages 128-132

  Valika, Aziz K ^a   Jain, Dhanpat ^a   Jaffe, Phillip E ^b   Moeckel, Gilbert ^a   Brewster, Ursula C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gastroenterology Center   (United States)

Author keywords

dialysis; end stage renal disease (ESRD); foreign body reaction; histiocytosis; hyperphosphatemia; Lanthanum carbonate; phosphate binder; upper gastrointestinal bleed

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; HEMOGLOBIN; IRON; LANTHANUM CARBONATE; METOPROLOL; PARICALCITOL; RALTEGRAVIR; RECOMBINANT ERYTHROPOIETIN; RITONAVIR; TENOFOVIR; LANTHANUM;

ADULT; ANEMIA; ARTICLE; CASE REPORT; COLONOSCOPY; DRUG WITHDRAWAL; DUODENUM BIOPSY; DYSPNEA; ELECTRON MICROSCOPY; END STAGE RENAL DISEASE; ENDOSCOPIC ECHOGRAPHY; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; FOREIGN BODY REACTION; GASTROENTERITIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LONG TERM CARE; MALE; MELENA; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RENAL REPLACEMENT THERAPY; STOMACH BIOPSY; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; VIRUS LOAD; CHEMICALLY INDUCED; TIME FACTOR;

FOREIGN-BODY REACTION; HUMANS; LANTHANUM; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 84955193988     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.07.033     Document Type: Article

References (21)

1. S.C. Palmer, A. Hayen, P. Macaskill, and et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis JAMA 305 11 2011 1119 1127
2. A.J. Hutchison, B. Maes, J. Vanwalleghem, and et al. Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate Nephron Clin Pract 100 1 2005 c8 c19
3. W.F. Finn SPD Lanthanum Study Group Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients Clin Nephrol 65 3 2006 191 202
4. C.J. Zhai, X.S. Yu, Q.L. Sun, and et al. Effect of lanthanum carbonate versus calcium based phosphate binders in dialysis patients: a meta-analysis Clin Nephrol 82 12 2014 372 378
5. H. Komaba, T. Kakuta, H. Suzuki, M. Hida, T. Suga, and M. Fukagawa Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia Nephrol Dial Transplant 30 1 2015 107 114
6. S.J. Damment, and M. Pennick Clinical pharmacokinetics of the phosphate binder lanthanum carbonate Clin Pharmacokinet 47 9 2008 553 563
7. M. Pennick, K. Dennis, and S.J. Damment Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate J Clin Pharmacol 46 7 2006 738 746
8. R.L. Davis, and J.L. Abraham Lanthanum deposition in a dialysis patient Nephrol Dial Transplant 24 10 2009 3247 3250
9. C. Muller, F. Chantrel, and B. Faller A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report Nephrol Dial Transplant 24 10 2009 3245 3247
10. M. Makino, K. Kawaguchi, H. Shimojo, H. Nakamura, M. Nagasawa, and R. Kodama Extensive lanthanum deposition in the gastric mucosa: the first histopathological report Pathol Int 65 1 2015 33 37
11. J. Haratake, C. Yasunaga, A. Ootani, S. Shimajiri, A. Matsuyama, and M. Hisaoka Peculiar histiocytic lesions with massive lanthanum deposition in dialysis patients treated with lanthanum carbonate Am J Surg Pathol 39 6 2015 767 771
12. B. Lacour, A. Lucas, D. Auchere, N. Ruellan, N.M. de Serre Patey, and T.B. Drueke Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration Kidney Int 67 3 2005 1062 1069
13. E. Slatopolsky, H. Liapis, and J. Finch Progressive accumulation of lanthanum in the liver of normal and uremic rats Kidney Int 68 6 2005 2809 2813
14. F. Albaaj, and A.J. Hutchison Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients Int J Clin Pract 59 9 2005 1091 1096
15. M.E. De Broe, P.C. D'Haese Lanthanum Study Group Improving outcomes in hyperphosphataemia Nephrol Dial Transplant 19 suppl 1 2004 i14 i18
16. G.B. Spaksovski, A. Sikole, S. Gelev, and et al. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbone and after 2 years of follow up Nephrol Dial Transplant 8 2006 2217 2224
17. P.C. D'Haese, G.B. Spasovski, A. Sikole, and et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients Kidney Int Suppl 85 2003 S73 S78
18. J. Xu, and E.A. Ling Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers J Anat 184 pt 2 1994 227 237
19. L. Voltaggio, D. Lam-Himlin, B.N. Limketkai, A.D. Singhi, and C.A. Arnold Message in a bottle: decoding medication injury patterns in the gastrointestinal tract J Clin Pathol 67 10 2014 903 912
20. B.J. Swanson, B.N. Limketkai, T.C. Liu, and et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury Am J Surg Pathol 37 11 2013 1686 1693
21. J.K. Greenson, S.B. Trinidad, S.A. Pfeil, and et al. Gastric mucosal calcinosis. Calcified aluminum phosphate deposits secondary to aluminum-containing antacids or sucralfate therapy in organ transplant patients Am J Surg Pathol 17 1 1993 45 50